AAAAI Podcast: Conversations from the World of Allergy

This episode discusses the allergy practice parameters and how clinicians can utilize these resources. Joint Task Force Co-Chairs David Golden, MD, FAAAAI, and Marcus Shaker, MD, MS, FAAAAI, offer their perspective and insight regarding evidence-based medicine and translation into clinical practice.      

Roxana Siles, MD, FAAAAI, discusses this newly approved biologic that targets thymic stromal lymphopoietin for the treatment of severe asthma. This discussion walks through all the details regarding how best to utilize biologic therapy in asthma management.      

AAAAI Annual Meeting Program Committee Chair, Leonard B. Bacharier, MD, FAAAAI, discusses plans for the upcoming in-person Annual Meeting, February 25-28 in Phoenix, AZ. This update discusses important safety protocols, virtual options for attendees, and insights into all the great programming planned for the meeting. A must listen for all those planning to attend!

AAAAI Annual Meeting Program Committee Chair, Leonard B. Bacharier, MD, FAAAAI, discusses plans for the upcoming in-person Annual Meeting, February 25-28 in Phoenix, AZ. This update discusses important safety protocols, virtual options for attendees, and insights into all the great programming planned for the meeting. A must listen for all those planning to attend!      

Infectious disease expert Andrew Nowalk, MD, PhD, discusses important information surrounding the new COVID-19 variant, Omicron. Listen now to learn more about COVID-19 mutations, transmission and how this latest variant may or may not impact the pandemic.      

AAAAI President Giselle S. Mosnaim, MD, MS, FAAAAI, discusses her path towards leadership, current presidential initiatives, and an update on the 2022 Annual Meeting.      

John Kelso, MD, FAAAAI, returns to recap all we’ve learned during the past year regarding the safety and efficacy of COVID-19 vaccines, including updates regarding booster doses and recent approval for children 5-11 years of age.      

Nicholas L. Rider, DO, FAAAAI, discusses the new AAAAI course designed to help clinicians better recognize and diagnose primary immunodeficiency. This free online course offers Part IV MOC and continuing education credit.      

Jennifer Namazy, MD, FAAAAI, discusses the accumulating evidence surrounding the safety and efficacy of COVID-19 vaccines during pregnancy. This timely and informative discussion is important for healthcare professionals, patients and the general public.      

David B. Peden, MD, MS, FAAAAI, is the new Editor-in-Chief for The Journal of Allergy and Clinical Immunology: Global (JACI: Global), a new Gold Open Access journal from the AAAAI that is launching in February 2022. Dr. Peden discusses the ins and outs of JACI: Global and how it will impact the specialty of allergy / immunology.      

World-renowned vaccine and infectious disease expert Peter Hotez, MD, PhD, DSc (hon), FASTMH, FAAP, joins us to discuss the latest information surrounding the COVID-19 pandemic. This important update discusses the Delta variant, full FDA approval of the Pfizer vaccine, third vaccine doses, the return to school, and much more.      

Pediatric allergist and food allergy expert Brian Vickery, MD, FAAAAI, joins us to discuss the Delta variant, safety of sending kids back to school and asthma/allergy management in the school setting. This is a timely episode for all parents, school personnel, clinicians and the general public!      

Pamela Guerrerio, MD, PhD, is the principal investigator for a newly launched research study conducted by the National Institutes of Health (NIH). She discusses the research questions being addressed as well as details surrounding inclusion/exclusion criteria and participant involvement.